How Google made peace with war
On April 27, more than 600 Google employees signed a letter urging CEO Sundar Pichai to prevent the…
businessinsider.com
VOR(VOR)
VOR
Earnings in 10 days · May 13, 2026 · After close
Signal
Mixed1↑1↓
PRICE
Prev Close
14.33
Open
14.18
Day Range13.68 – 14.32
13.68
14.32
52W Range2.62 – 65.80
2.62
65.80
18% of range
VOLUME & SIZE
Avg Volume
990.1K
FUNDAMENTALS
P/E Ratio
-0.2x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.31
Market-like
Quick Read
Trend—Insufficient MA data
Momentum
BEARISH
thin 0% gross marginValuation
FAIR
P/E not availableHealth
MODERATE
CR 18.2 · FCF negativeNeutral
Key MetricsTTM
Market Cap$94.93M
Revenue TTM$0.00
Net Income TTM-$695.98M
Free Cash Flow-$143.65M
Gross Margin0.0%
Net Margin0.0%
Operating Margin0.0%
Return on Equity72.7%
Return on Assets-150.0%
Debt / Equity-0.02
Current Ratio18.20
EPS TTM$-70.50
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
4 strong2 concern
67/100Liquidity
18.20Strong
Leverage
-0.02Strong
Coverage
0.0xConcern
ROE
72.7%Strong
ROIC
-84.6%Concern
Cash
$396MStrong
ANALYST COVERAGE13 analysts
BUY
▲ +178.0%upside to target
L $31.00
Med $38.50consensus
H $46.00Stock Health
Composite Score
4 of 4 signals bullish
10/10
Technicals
●
✓RSI RangeRSI 50 — Bullish momentum
Fundamentals
●
✓Last EarningsBeat estimates
●
✓Analyst ConsensusBuy
●
✓LiquidityCurrent Ratio 18.20 — healthy liquidity
1 signal unavailable — limited data for this stock
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentOct 9, 2026
In 159 days
FinancialsFull statements →
Technicals
Technical SetupBULLISH
Technicals →Trend
→ PullbackGolden Cross · 50D leads 200D by 68.5%
-1.3% vs SMA 50 · +66.3% vs SMA 200
Momentum
RSI50.1Neutral territory
MACD+0.11Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$65.80+375.1%
EMA 50
$13.89+0.3%
Current
$13.85
EMA 200
$8.33-39.9%
52W Low
$2.62-81.1%
52-Week RangeNear 52-week low
$2.6218th %ile$65.80
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 9 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $2.0M $2.0M–$2.0M | — | -$69.75 | — | ±0% | High5 |
FY2026(current) | $4.2M $4.2M–$4.2M | ▲ +108.3% | -$3.58 | — | ±17% | High7 |
FY2027 | $10.0M $10.0M–$10.0M | ▲ +140.0% | -$3.96 | — | ±9% | High9 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryVOR
Last 8Q
+868.8%avg beat
Beat 1 of 8 quartersMissed 5↓ Estimates falling-22%
Q2'24
—
Q3'24
—
Q4'24
-29%
Q1'25
-4%
Q2'25
-282%
Q3'25
-9%
Q4'25
+7296%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightInsider Activity
SEC Filings →0 Buys/6 SellsNet Selling
NET SELLERS$0 bought · $44.7M sold · 30d window
Ra Capital Manageme…Dir
$2.6M
Apr 22
SELL
Ra Capital Manageme…Dir
$7.5M
Apr 17
SELL
Ra Capital Manageme…Dir
$2.7M
Apr 20
SELL
Ra Capital Manageme…Dir
$8.6M
Apr 13
SELL
Ra Capital Manageme…Dir
$2.5M
Apr 14
SELL
Ra Capital Manageme…Dir
$859K
Apr 15
SELL
Financials
INSTITUTIONAL OWNERSHIP
1
Simplify Asset Management Inc.
54K▲2
PROFUND ADVISORS LLC
22K▲3
Cannon Global Investment Management, LLC
12K▲4
China Universal Asset Management Co., Ltd.
7K▲5
GF FUND MANAGEMENT CO. LTD.
372▲6
SIGNATUREFD, LLC
39▲7
Fortitude Family Office, LLC
31▲8
WPG Advisers, LLC
21▲News & Activity
VOR News
20 articles · 4h ago
OPEC+ set to agree third oil output quota hike since Hormuz closure, sources say
reuters.com
LEO: Tax-Free Yield And Measured Duration Exposure
seekingalpha.com
Melco Resorts: Q1 2026 Earnings Confirms Our Bullish Case
seekingalpha.com
Smartee Showcases Clinical Innovations in Mandibular Repositioning and Strengthens European Presence at EAS Congress 2026
prnewswire.com
Is Nvidia's Deal With Oklo a Game Changer?
fool.com
Israel approves plan to buy F-35 and F-15I aircraft from US
reuters.com
EgyptAir Takes Delivery of First Boeing 737 MAX Jet
prnewswire.com
Robinhood's Crypto Revenue Took a Hit. Is the Long-Term Story Still Intact?
fool.com
Goldman Sachs Says the Artificial Intelligence (AI) Software Sell-Off Was Overdone. Here Are the Best Growth Stocks to Buy Now.
fool.com
American Express: The Subscription Moat With A Potential AI Bonus On Top
seekingalpha.com
My Top 2 Industrial Stocks for the Iran War Era
fool.com
Alphabet Is Dropping $190 Billion on AI Infrastructure: 3 Semiconductor Stocks Set to Win Big
fool.com
AI chatbot fraud: the ‘gift card' subcription that may cost you dear
theguardian.com
Tyler Technologies: Encouraging Recovery In Bookings (Rating Upgrade)
seekingalpha.com
Why ServiceNow Stock Fell 16% in April
fool.com
Hamilton Insurance: Rally Has Largely Closed The Valuation Gap (Rating Downgrade)
seekingalpha.com
Crypto News: Ethereum Based Crypto Pepeto Announces $9.78 Million Raised While Cardano Price Prediction Turns Bullish
globenewswire.com
My Top 5 Stocks to Buy in May
fool.com
StellarSpace, Silikon Vadisi Lansman Etkinliğinde Yeni Nesil Endüstriyel Otomasyon Ürünlerini İlk Defa Tanıttı
globenewswire.com
About
Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells.
Industry
Research and Development in Biotechnology
Website